CGM improves time in range, reduces HbA1c for older adults with type 1 diabetes
Older adults with type 1 diabetes initiating continuous glucose monitoring for the first time had a reduction in time spent in hypoglycemia, improved time in range and a lower HbA1c, according to findings from a randomized clinical trial. In the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study, adults aged 60 years and older with type 1 diabetes randomly assigned to CGM had